Pulmonary Apical Cap as a Potential Risk Factor for Pleuroparenchymal Fibroelastosis
نویسندگان
چکیده
منابع مشابه
Idiopathic Pleuroparenchymal Fibroelastosis
PURPOSE OF THE REVIEW Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare fibrosing lung disease, affecting the visceral pleura and the subpleural parenchyma with an upper lobe predilection, included as a distinct clinicopathologic entity in the latest international multidisciplinary classification of the idiopathic interstitial pneumonias (IIP). We aim to summarize the current eviden...
متن کاملPleuroparenchymal fibroelastosis as a late complication of chemotherapy agents
We identified six patients with clinical, radiographic and physiological features typical of pleuroparenchymal fibroelastosis (PPFE). In the six cases, PPFE may have been causally related to prior alkylating drugs used to treat malignacy, namely cyclophosphamide in five of the cases and carmustine (BCNU (1,3-bis-(2chloroethyl)-1-nitrosourea)) in one. Based on an extensive review of the literatu...
متن کاملPleuroparenchymal Fibroelastosis: Its Clinical Characteristics
Pleuroparenchymal fibroelastosis (PPFE) is a rare pulmonary fibrosis that is clinically characterized by upperlobe predominant fibrosis. PPFE is a slowly progressive disorder and its first symptom is dyspnea or dry cough. Chest pain because of pneumothorax may be the first symptom in some patients. Patients with PPFE are slender with a flat rib cage or abnormally narrowed anterior-posterior tho...
متن کاملPleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?
Statement of Interest: Statements of interest for S. Birring and I. Pavord can be found at www.erj.ersjournals.com/site/misc/ statements.xhtml REFERENCES 1 Pavord ID, Chung KF. Management of chronic cough. Lancet 2008; 371: 1375–1384. 2 Morice AH, McGarvey L, Pavord ID. Recommendations for the management of cough in adults. Thorax 2006; 61: 1–24. 3 Birring SS, Fleming T, Matos S, et al. The Lei...
متن کاملPleuroparenchymal fibroelastosis as a late complication of chemotherapy agents.
We identified six patients with clinical, radiographic and physiological features typical of pleuroparenchymal fibroelastosis (PPFE). In the six cases, PPFE may have been causally related to prior alkylating drugs used to treat malignacy, namely cyclophosphamide in five of the cases and carmustine (BCNU (1,3-bis-(2chloroethyl)-1-nitrosourea)) in one. Based on an extensive review of the literatu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Chest
سال: 2021
ISSN: 0012-3692
DOI: 10.1016/j.chest.2021.01.011